List of Tables
Table 1. Angiotensin Converting Enzyme (ACE) Inhibitors Market Trends
Table 2. Angiotensin Converting Enzyme (ACE) Inhibitors Market Drivers & Opportunity
Table 3. Angiotensin Converting Enzyme (ACE) Inhibitors Market Challenges
Table 4. Angiotensin Converting Enzyme (ACE) Inhibitors Market Restraints
Table 5. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Company (2019-2024)
Table 7. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume by Company (2019-2024) & (K MT)
Table 8. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Angiotensin Converting Enzyme (ACE) Inhibitors Price by Company (2019-2024) & (USD/MT)
Table 10. Key Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Angiotensin Converting Enzyme (ACE) Inhibitors
Table 13. Global Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin Converting Enzyme (ACE) Inhibitors as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
Table 22. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume by Type (2019-2024) & (K MT)
Table 23. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume by Type (2025-2030) & (K MT)
Table 24. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2019-2024) & (USD/MT)
Table 27. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2025-2030) & (USD/MT)
Table 28. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
Table 34. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume by Application (2019-2024) & (K MT)
Table 35. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume by Application (2025-2030) & (K MT)
Table 36. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2019-2024) & (USD/MT)
Table 39. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2025-2030) & (USD/MT)
Table 40. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Region (2019-2024) & (%)
Table 44. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Region (2025-2030) & (%)
Table 45. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
Table 46. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume by Region (2019-2024) & (K MT)
Table 47. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume by Region (2025-2030) & (K MT)
Table 48. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume by Region (2019-2024) & (%)
Table 49. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume by Region (2025-2030) & (%)
Table 50. Global Angiotensin Converting Enzyme (ACE) Inhibitors Average Price by Region (2019-2024) & (USD/MT)
Table 51. Global Angiotensin Converting Enzyme (ACE) Inhibitors Average Price by Region (2025-2030) & (USD/MT)
Table 52. Key Countries/Regions Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume, (2019-2024) & (K MT)
Table 56. Key Countries/Regions Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume, (2025-2030) & (K MT)
Table 57. Abbott Laboratories Company Information
Table 58. Abbott Laboratories Introduction and Business Overview
Table 59. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 61. Abbott Laboratories Recent Development
Table 62. Pfizer Company Information
Table 63. Pfizer Introduction and Business Overview
Table 64. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 65. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 66. Pfizer Recent Development
Table 67. Novartis Company Information
Table 68. Novartis Introduction and Business Overview
Table 69. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 70. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 71. Novartis Recent Development
Table 72. Merck Company Information
Table 73. Merck Introduction and Business Overview
Table 74. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 75. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 76. Merck Recent Development
Table 77. Astra Zeneca Company Information
Table 78. Astra Zeneca Introduction and Business Overview
Table 79. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 80. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 81. Astra Zeneca Recent Development
Table 82. Jhonson and Johnson Company Information
Table 83. Jhonson and Johnson Introduction and Business Overview
Table 84. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 85. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 86. Jhonson and Johnson Recent Development
Table 87. Eli Lilly Company Information
Table 88. Eli Lilly Introduction and Business Overview
Table 89. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 90. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 91. Eli Lilly Recent Development
Table 92. Sanofi Company Information
Table 93. Sanofi Introduction and Business Overview
Table 94. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 95. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 96. Sanofi Recent Development
Table 97. Bristol-Myers Squibb Company Information
Table 98. Bristol-Myers Squibb Introduction and Business Overview
Table 99. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 100. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 101. Bristol-Myers Squibb Recent Development
Table 102. Bayer Company Information
Table 103. Bayer Introduction and Business Overview
Table 104. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 105. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 106. Bayer Recent Development
Table 107. GSK Company Information
Table 108. GSK Introduction and Business Overview
Table 109. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 110. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 111. GSK Recent Development
Table 112. Teva Pharmaceutical Company Information
Table 113. Teva Pharmaceutical Introduction and Business Overview
Table 114. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 115. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 116. Teva Pharmaceutical Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Angiotensin Converting Enzyme (ACE) Inhibitors Downstream Customers
Table 120. Angiotensin Converting Enzyme (ACE) Inhibitors Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiotensin Converting Enzyme (ACE) Inhibitors Product Picture
Figure 2. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume (2019-2030) & (K MT)
Figure 5. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Price (2019-2030) & (USD/MT)
Figure 6. Angiotensin Converting Enzyme (ACE) Inhibitors Report Years Considered
Figure 7. Global Angiotensin Converting Enzyme (ACE) Inhibitors Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Angiotensin Converting Enzyme (ACE) Inhibitors Players Sales Volume Ranking (2023) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Angiotensin Converting Enzyme (ACE) Inhibitors Revenue in 2023
Figure 10. Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Sulfhydryl-containing Agents Picture
Figure 12. Dicarboxylate-containing Agents Picture
Figure 13. Phosphonate-containing Agents Picture
Figure 14. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
Figure 17. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2019-2030) & (USD/MT)
Figure 19. Product Picture of Hypertension
Figure 20. Product Picture of Cardiovascular Diseases
Figure 21. Product Picture of Kidney Diseases
Figure 22. Product Picture of Other
Figure 23. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
Figure 26. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2019-2030) & (USD/MT)
Figure 28. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Angiotensin Converting Enzyme (ACE) Inhibitors Sales Volume (%), (2019-2030)
Figure 40. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 46. China Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 48. China Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 58. India Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 60. India Angiotensin Converting Enzyme (ACE) Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 61. Angiotensin Converting Enzyme (ACE) Inhibitors Industrial Chain
Figure 62. Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
